Suchergebnisse - "Zheng, S.Lilly"

PubPharm (5)

1

Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality : A Population-based Prospective Analysis

enthalten in: European urology | 2021

von Shi, Z. | Platz, E. | Wei, J. | +11

CommentIn: Nat Rev Urol. 2021 Feb;18(2):72. - PMID 33408352

2

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer

enthalten in: European urology | 2019

von Carter, H. | Helfand, B. | Mamawala, M. | +14

CommentIn: Eur Urol. 2019 May;75(5):750-751. - PMID 30482669

3

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

enthalten in: European urology | 2017

von Na, R. | Zheng, S. | Han, M. | +34

CommentIn: Eur Urol. 2017 May;71(5):748-749. - PMID 28131466

4

Genetic score is an objective and better measurement of inherited risk of prostate cancer than family history

enthalten in: European urology | 2013

von Sun, J. | Na, R. | Hsu, F. | +5

5

Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy : findings from the REDUCE trial

enthalten in: European urology | 2012

von Kader, A. | Sun, J. | Reck, B. | +21

CommentIn: Eur Urol. 2012 Dec;62(6):962-3; discussion 964-5. - PMID 22749734

1
[1]